Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
126
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial

Jemi Galani1 Department of Medicine, Duke University Medical Center, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0002-4920-7809View further author information
ORCID Icon,
Hillary Mulder2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USAView further author information
,
Frank W Rockhold2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0003-3732-4765View further author information
ORCID Icon,
E Hope Weissler2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA;3 Department of Surgery, Division of Vascular Surgery, Duke University Health System, Durham, NC, USAView further author information
,
Iris Baumgartner4 Department of Medicine, Swiss Cardiovascular Center, University of Bern, Bern, SwitzerlandView further author information
,
Jeffrey S Berger5 Departments of Medicine and Surgery, New York University School of Medicine, New York, NY, USAView further author information
,
Juuso I Blomster6 University of Turku, Turku, FinlandView further author information
,
F Gerry R Fowkes7 Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UKView further author information
,
William R Hiatt8 Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA;9 CPC Clinical Research, Aurora, CO, USAView further author information
,
Brian G Katona10 AstraZeneca, Gaithersburg, MD, USAView further author information
,
Lars Norgren11 Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information
,
Kenneth W Mahaffey12 Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, CA, USAView further author information
,
Jennifer K Quint13 Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College London, London, UKORCID Iconhttps://orcid.org/0000-0003-0149-4869View further author information
ORCID Icon,
Manesh R Patel1 Department of Medicine, Duke University Medical Center, Durham, NC, USA;2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USAView further author information
&
W Schuyler Jones1 Department of Medicine, Duke University Medical Center, Durham, NC, USA;2 Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USACorrespondence[email protected]
View further author information
 show all
Pages 841-851 | Published online: 29 Mar 2021

References

  • Lozano R, Naghavi M, Foreman K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • Negewo N, Gibson P, McDonald V. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171. doi:10.1111/resp.12642
  • Fabbri L, Rabe K. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799. doi:10.1016/S0140-6736(07)61383-X
  • Fowkes F, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
  • Houben-Wilke S, Jorres R, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences - comorbidities network study. Am J Respir Crit Care Med. 2017;195:189–197. doi:10.1164/rccm.201602-0354OC
  • Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil. 2008;15(3):270–277. doi:10.1097/HJR.0b013e3282f009a9
  • Crisafulli E, Scelfo C, Tzani P, Aiello M, Bertorelli G, Chetta A. Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation. Eur J Prev Cardiol. 2017;24(9):990–999. doi:10.1177/2047487317695629
  • de Liefde II, Van Domburg R, Bax J, Klein J, Verhagen H, Poldermans D. A decline in walking distance predicts long-term outcome in patients with known or suspected peripheral artery disease. Eur J Cardiovasc Prev Rehabil. 2009;38:482–487.
  • Hiatt WR, Fowkes FG, Heizer G, et al. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017;376(1):32–40. doi:10.1056/NEJMoa1611688
  • Berger J, Katona B, Jones W, et al. Design and rationale for the effects of ticagrelor and clopidogrel in patients with peripheral artery disease (EUCLID) trial. Am Heart J. 2016;175:86–93. doi:10.1016/j.ahj.2016.01.018
  • Kaszuba M, Śliwka A, Piliński R, et al. The comorbidity of chronic obstructive pulmonary disease and peripheral artery disease–a systematic review. J Chronic Obstruct Pulmon Dis. 2019;16:292–302. doi:10.1080/15412555.2019.1653271
  • Terzikhan N, Lahousse L, Verhamme K, et al. COPD is associated with an increased risk of peripheral artery disease and mortality. ERJ Open Res. 2018;4(4):00086–2018. doi:10.1183/23120541.00086-2018
  • Kunisaki K, Dransfield M, Anderson J, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018;198(1):51–57. doi:10.1164/rccm.201711-2239OC
  • McDermott M, Tian L, Wunderink R, et al. Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery disease. Vasc Med. 2017;22(3):218–224. doi:10.1177/1358863X16680461
  • Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264–274. doi:10.1001/jama.2014.18229
  • Rothnie K, Mullerova H, Smeeth L, Pearce N, Douglas I, Quint J. Risk of myocardial infarction associated with acute exacerbations of COPD: effects of exacerbation frequency. ERJ. 2016;48:PA3107.
  • Saaby L, Poulsen T, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126(9):789–797. doi:10.1016/j.amjmed.2013.02.029
  • Arora S, Shemisa K, Vaduganathan M, et al. Premature ticagrelor discontinuation in secondary prevention of atherosclerotic CVD. J Am Coll Cardiol. 2019;73(19):2454–2464. doi:10.1016/j.jacc.2019.03.470
  • Bender B. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next? Curr Opin Pulm Med. 2014;20(2):132–137. doi:10.1097/MCP.0000000000000027
  • Rogliani P, Ora J, Puxeddu E, Matera M, Cazzola M. Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117–123. doi:10.1016/j.rmed.2017.06.007
  • Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
  • Beghe B, Verduri A, Roca M, Fabbri LM. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993–995. doi:10.1183/09031936.00180812

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.